Anti-RSBN1L monoclonal antibody

Pre-made anti-RSBN1L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RSBN1L/RSBN1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2719-Ab-1/ GM-Tg-hg-IP2719-Ab-2Anti-Human RSBN1L monoclonal antibodyHuman
GM-Tg-rg-IP2719-Ab-1/ GM-Tg-rg-IP2719-Ab-2Anti-Rat RSBN1L monoclonal antibodyRat
GM-Tg-mg-IP2719-Ab-1/ GM-Tg-mg-IP2719-Ab-2Anti-Mouse RSBN1L monoclonal antibodyMouse
GM-Tg-cynog-IP2719-Ab-1/ GM-Tg-cynog-IP2719-Ab-2Anti-Cynomolgus/ Rhesus macaque RSBN1L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2719-Ab-1/ GM-Tg-felg-IP2719-Ab-2Anti-Feline RSBN1L monoclonal antibodyFeline
GM-Tg-cang-IP2719-Ab-1/ GM-Tg-cang-IP2719-Ab-2Anti-Canine RSBN1L monoclonal antibodyCanine
GM-Tg-bovg-IP2719-Ab-1/ GM-Tg-bovg-IP2719-Ab-2Anti-Bovine RSBN1L monoclonal antibodyBovine
GM-Tg-equg-IP2719-Ab-1/ GM-Tg-equg-IP2719-Ab-2Anti-Equine RSBN1L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2719-Ab-1/ GM-Tg-hg-IP2719-Ab-2; GM-Tg-rg-IP2719-Ab-1/ GM-Tg-rg-IP2719-Ab-2;
GM-Tg-mg-IP2719-Ab-1/ GM-Tg-mg-IP2719-Ab-2; GM-Tg-cynog-IP2719-Ab-1/ GM-Tg-cynog-IP2719-Ab-2;
GM-Tg-felg-IP2719-Ab-1/ GM-Tg-felg-IP2719-Ab-2; GM-Tg-cang-IP2719-Ab-1/ GM-Tg-cang-IP2719-Ab-2;
GM-Tg-bovg-IP2719-Ab-1/ GM-Tg-bovg-IP2719-Ab-2; GM-Tg-equg-IP2719-Ab-1/ GM-Tg-equg-IP2719-Ab-2
Products NameAnti-RSBN1L monoclonal antibody
Formatmab
Target NameRSBN1L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RSBN1L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2719-Ag-1Recombinant multi-species RSBNL/ RSBN1L protein


    Target information

    Target IDGM-IP2719
    Target NameRSBN1L
    Gene ID222194,242860,311987,693814,483278,101088914,541150,100057295
    Gene Symbol and Synonyms8430412F05Rik,C330002G24Rik,RGD1308748,RSBN1L
    Uniprot AccessionQ6PCB5
    Uniprot Entry NameRSBNL_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187257
    Target ClassificationN/A

    The target: RSBN1L, gene name: RSBN1L, also named as . Predicted to enable dioxygenase activity and metal ion binding activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.